Chen et al. enrolled a total of 29 patients with EGFR-mutant advanced lung adenocarcinomas who also underwent surgical resection; the median PFS after surgery was 36.4 months, and the median OS was still not reached [27]. This evidence concerns the gene EGFR and lung adenocarcinoma.